Applied BioCode Unit Gets US FDA Nod for Respiratory Pathogen Panel

MT Newswires Live
Yesterday

Applied BioCode's (TPE:6598) US unit has secured a 510(k) clearance from the U.S. FDA for its respiratory pathogen panel, according to a Monday Taiwan Exchange filing.

The approval allows the panel to be used with the BioCode MDx 3000 system alongside Thermo Fisher Scientific's KingFisher extraction platform, adding to existing compatibility with systems from bioMérieux and Roche.

The company said the clearance enables sales of the combined solution in the US, offers labs greater flexibility in extraction systems, and is expected to support its business and financial performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10